Drug reference
aldesleukin
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Oncology (TK Inhibitors)
Mechanism of action
Recombinant human interleukin-2; stimulates lymphokines-activated killer cells and tumor-infiltrating lymphocytes cells following the interaction between malignant cells and the immune system. Cytolytic for a subset of lymphocytes; promotes differentiation, proliferation and recruitment of B and T cells, thymocytes and natural killer cells.
Common side effects
- Rash
- Vomiting
- Dyspnea
- Hypotension
- Chills
- Oliguria
- Diarrhea
Related conditions
Frequently asked questions
What drug class is aldesleukin?
aldesleukin belongs to: Oncology.
How does aldesleukin work?
Recombinant human interleukin-2; stimulates lymphokines-activated killer cells and tumor-infiltrating lymphocytes cells following the interaction between malignant cells and the immune system. Cytolytic for a subset of lymphocytes; promotes differentiation, proliferation and recruitment of B and T cells, thymocytes and natural killer cells.
What are the common side effects of aldesleukin?
Rash, Vomiting, Dyspnea, Hypotension, Chills, Oliguria, Diarrhea
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.